Molecular Biomedicine is an Open Access publication and an article-processing charge (APC) is levied on articles that are accepted for publication by the Editors.
The APC for this journal is covered by Sichuan International Medical Exchange & Promotion Association, in 2020-2022.
Article Types
Research
Articles describe original research, and should be 3000-6000 words (excluding the abstract, tables, figure legends and references) and contain no more than 8 display items (such as figures or tables).
Research papers should contain an unstructured abstract with up to 250 words. Additional display items will be published online as Supplemental Information.
Review
A review should be a comprehensive synthesis and/or analysis of specific topics. A short Introduction giving the rationale for the review should be followed by sections with appropriate subheadings, followed by a conclusions section at the end. The standard footer headings (Acknowledgements, Contributions, Competing Interests, and Funding) are required. All invited reviews will undergo peer review prior to acceptance.
Review papers should contain an unstructured abstract with up to 250 words, at least 3000 words in length. Review papers should contain around 4-8 figures and tables in total, around 100-500 references.
Letter
Letters provide rapid and concise report of a novel finding that is brief in nature but is of general interest to the field. There should be no more than 10 authors.
No abstract needed for Letter papers. It should include 1200 words max excluding references, figures and tables. A letter should contain, but no more than 1 display item and references are limited to 5.
Research Highlight
Research Highlights discuss the main advances made by the paper as well as putting the finds of the study into the proper context of the field.
A brief stand first of one or two sentences should serve as an abstract. A research highlight paper should include 1000 words max excluding references, figures and tables, and contain, but no more than 1 display item and references are limited to 5. A consensus should be a public statement on professional knowledge in the field of molecular biomedicine, and it is expected to be generally agreed upon as an evidence-based, state-of-the-art knowledge by a representative group of experts in that area.
Consensus
Consensus papers should contain an unstructured Abstract with up to 250 words. Four to Six Keywords representing the main content of the article. The Background section should a concise summary of a search of the existing literature and the issue under discussion. The standard footer headings (Acknowledgements, Contributions, Competing Interests, and Funding) are required.
Manuscript Submission
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.
Permissions
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
Online Submission
Please follow the hyperlink “Submit manuscript” and upload all of your manuscript files following the instructions given on the screen.
Source Files
Please ensure you provide all relevant editable source files at every submission and revision. Failing to submit a complete set of editable source files will result in your article not being considered for review. For your manuscript text please always submit in common word processing formats such as .docx or LaTeX.
